Podcast Episodes

Back to Search
“Major Wins” in Lung Cancer Treatment: How “Explosion of Data” Is Changing Practice

Within the last few years, an “explosion of data” regarding adjuvant and neoadjuvant treatment for resectable lung cancer has contained “major wins”…

2 years, 10 months ago

Short Long
View Episode
“Great Therapies for All-Comers” in CLL: How Can Oncologists “Pick and Choose?”

As treatment options increase for patients with CLL, so do questions about which interventions, if any, are right for which patients and when. Bob Fi…

2 years, 11 months ago

Short Long
View Episode
Pragmatica-Lung Tests a Treatment and a New Approach to Trials

The newly opened Pragmatica-Lung trial compares ramucirumab plus pembrolizumab versus usual care for treatment of stage IV or recurrent non-small cel…

3 years ago

Short Long
View Episode
The Best First Step in Metastatic NSCLC Care

With more than 10 known driver mutations in non-small cell lung cancer (NSCLC), testing is ever more critical, says Heather Wakelee, MD, division ch…

3 years ago

Short Long
View Episode
Neo- and Adjuvant Treatments Are Changing Care in Early NSCLC

Treatment options are expanding quickly in early non-small cell lung cancer. Listen as Heather Wakelee, MD, division chief of Medical Oncology at Sta…

3 years ago

Short Long
View Episode
NALIRIFOX Changes Care in Pancreatic Cancer: Here’s How

After a decade of limited gains in metastatic pancreatic cancer, Zev Wainberg, MD, professor of medicine and co-director of the GI oncology program a…

3 years, 1 month ago

Short Long
View Episode
Matching Breast Cancer Patients to Therapies: Here’s How

Season 1 Episode 1

The landscape for breast cancer treatment is shifting quickly, with an ever-increasingemphasis on targeted and hormonal therapies. Listen as Virgi…

3 years, 3 months ago

Short Long
View Episode
Myelofibrosis Remains Tough to Treat, But New Drugs Are Paving the Way

Listen as Gabriela Hobbs, MD, clinical director of the leukemia atMass General, talks with Bob Figlin, MD, the Steven Spielberg Family Chair in Hemat…

3 years, 4 months ago

Short Long
View Episode
KRAS Inhibition in NSCLC: When, How, and Why?

Melissa Johnson, MD,a medical oncologist with Tennessee Oncology and Director of Lung Cancer Research at Sarah Cannon Research Institute in Nashville…

3 years, 4 months ago

Short Long
View Episode
Strategies for Navigating a Hematology/Oncology Fellowship

The key steps to launching a successful and professionally fulfilling hematology/oncology fellowship is to “reflect, project, and adapt,” according t…

3 years, 4 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us